ACT-3 Reactor-based boron neutron capture therapy with add-on bevacizumab for recurrent malignant glioma: The final report

Background: Re-irradiation had a higher rate of radiation injury because recurrent MG had already irradiated in the first-line treatment. Recently, combination therapy of re-irradiation and bevacizumab showed a lower incidence of radiation injury than re-irradiation alone. Boron neutron capture ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Furuse, Motomasa, Kawabata, Shinji, Wanibuchi, Masahiko, Shiba, Hiroyuki, Takeuchi, Koji, Kondo, Natsuko, Tanaka, Hiroki, Sakurai, Yoshinori, Suzuki, Minoru, Ono, Koji, Miyatake, Shin-Ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664641/
http://dx.doi.org/10.1093/noajnl/vdab159.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664641/
http://dx.doi.org/10.1093/noajnl/vdab159.034

Ejemplares similares